Highcape Capital Acquisition Corp. are a newly organized blank check company incorporated in June 2020 as a Delaware corporation formed for the purpose of combining with one or more businesses. They have not selected any specific business combination target as of yet. In the SEC filing they state "While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background in life sciences and life sciences related industries, and to capitalize on the ability of our management team to identify and acquire a business within those industries".
Their strategy will be to identify, acquire and, after our initial business combination, build, a life sciences or life sciences related business. They intend to focus their investment effort broadly across the entire life sciences industry, which encompasses therapeutics, devices, diagnostics, medical information technology, agrisciences and animal health.
Units (CAPAU) are priced at $10 and include one common share and 1/2 of a warrant, warrants are exercisable at $11.50
Share the story on social media!
In Other News!